MedPath

Voice Activated Personal Assistant for Depression Among Older Adults

Not Applicable
Active, not recruiting
Conditions
Depression, Anxiety
Interventions
Behavioral: Alexa with Guidebook
Behavioral: VIPA Treatment Program
Registration Number
NCT06114485
Lead Sponsor
Northwestern University
Brief Summary

Participants will use Amazon Alexa to test a new voice-assisted program for mental health management. The participant will use this program to help with goal setting, reminders, and various other services. The participant may be supported by a caregiver, if available, or by research team member who will serve as a coach for the duration of the study to guide them with using the program. Participants will be asked to complete surveys and assessments about their experiences during the 12-week study period. Participants will be randomized into two groups: those who receive a guide to help them with utilization of the program to its fullest potential and those who do not receive that guide.

Detailed Description

Older adults have often been on the fringe of benefiting from technology. However, voice-controlled intelligent personal assistants (VIPAs; e.g. Google Home, Amazon Echo), with their natural interaction style and ease of use, are a simple interface technology that may be useful to older adults with depression in the home setting. The caregiver or coach will be able to schedule and follow the interactions between the older adult and the VIPA. The VIPAs would potentially be able to provide functional, cognitive, and social stimulation as well as improve anti-depressant medication adherence through reminders to older adults.

The aim is to evaluate a VIPA that was designed to deliver behavioral activation prompts to older adults with depression. Through user centered design (UCD), the investigators have adapted the model for remote support with the aid of VIPAs that provide psychoeducation, as well as features that support social, cognitive, and functional stimulation and reminders.

The intervention will be 8 weeks, with a 4-week follow-up. During 8-week intervention, participants will be able to use Amazon Echo Show 8 and the study's VIPA program to set goals, reminders, and the like to help with their mood. Participants will also be asked to completed associated assessments. If caregivers are involved, they will also be asked to complete assessments.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control Treatment (CT)Alexa with GuidebookParticipants randomized to Arm 2 will be sent an Amazon Alexa device with guidebook to help the older adult and their caregiver understand how to use the device.
Digital Mental Health Intervention (DMHI)VIPA Treatment ProgramParticipants randomized to Arm 1 will be sent an Amazon Alexa device, with a newly designed VIPA treatment program installed, and will receive a guidebook to help the older adult and their caregiver understand the device and utilize the VIPA treatment program to its fullest potential.
Primary Outcome Measures
NameTimeMethod
Anxiety symptoms12 weeks

The Generalized Anxiety Disorder-7 (GAD-7) measures anxiety symptom severity on a scale of 0-21, with higher scores indicating greater severity

Depressive symptoms12 weeks

The Patient Health Questionnaire-9 (PHQ-9) PHQ-9 measures depression symptom severity on a scale of 0-27, with higher scores indicating greater symptom severity.

The PHQ-9 measures depressive symptom severity on a scale of 0-27, with higher scores indicating greater severity

Secondary Outcome Measures
NameTimeMethod
Adherence8 weeks

The number of times the Alexa device was accessed (Usage; # communications with TES-VIPA)

Trial Locations

Locations (1)

Northwestern University

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath